Final ICH E6 (R2) Guideline on Good Clinical Practices
The Real Impact of the Changes


Wednesday, May 27, 2020 • 1:30 p.m. - 3:00 p.m. EDT

The recent ICH GCP E6 (R2) addendum, which contains 26 significant changes, affects the conduct of your clinical trials. How will these changes impact your team, investigators sites, sponsors and clinical research organizations?

In this upcoming webinar, Marina Malikova, Ph.D., MSci, MA, CCRA, RAC, will cover these changes — new sections on investigator responsibilities, a new sponsor section on quality management, new section on computer validation and electronic records as well as updates on monitoring plans, risk-based quality management system and serious breaches — while providing solutions on how to build or update your organization’s SOPs, processes and practices. She’ll also share tips on how to modify your study designs.

Webinar Takeaways:

  • GCP E6 Guideline R2 Addendum overview and areas of changes, including new sections on investigator responsibilities and the substantial new sponsor section on quality management
  • Implementation of revised regulatory guidelines, including those affecting globalization issues
  • Introduction of risk-based quality management (RBQM), including those affecting serious breaches
  • Development of SOPs, including those on validation and electronic records

Are you ready to implement new and up-to-date approaches to clinical trial design, conduct, oversight, recording and reporting? Join us by registering today.

Who Will Benefit

  • Directors of clinical operations
  • Medical affairs specialists and leaders of clinical operations
  • Project managers of clinical operations
  • Staff from pharmaceutical/device companies or contract research organizations (CROs) involved with the management of clinical trials
  • New clinical or other project team leaders who will be managing projects
  • Clinical, regulatory, research and development (R&D) staff who will design clinical trial programs
  • Clinical research coordinators (CRCs) and clinical research associates (CRAs), data managers, or others working in biomedical product development and/or interested in transitioning into clinical trials field
  • Grant administrators
  • Regulatory affairs personnel
  • Quality control (QC) specialists and quality assurance specialists

Webinar plus USB Audio Recording/Transcript
Learn more

$487

add to cart

Webinar only
Learn more

$287

add to cart

24/7 Encore plus USB Audio Recording/Transcript
Learn more

$487

add to cart

24/7 Encore Presentation
Learn more

$287

add to cart

USB Audio Recording/Transcript
Learn more

$287

add to cart

 

Meet Your Presenter

Marina Malikova, Ph.D., MSci, MA, CCRA, RAC

Assistant Professor of Surgery
Boston University School of Medicine

Marina Malikova, Ph.D., MSci, MA, CCRA, RAC, is an assistant professor of surgery and executive director of surgical translational research, operations and compliance at Boston University School of Medicine. She has over 15 years of experience in the clinical research field and has managed Phase I–IV studies involving investigational drugs, devices and biologics. Dr. Malikova has worked on industry-sponsored and investigator-initiated trials in the fields of surgery, cancer diagnostics and interventional radiology.